Conexeu Sciences Introduces Human Collagen Program For Regenerative Aesthetics
Benzinga Newsdesk 6 hours ago
News
Conexeu Sciences Inc. (NASDAQ:CNXU) ("Conexeu" or the "Company"), a preclinical-stage medical device and regenerative medicine company advancing CXU™, an investigational tissue-restoration platform,
Conexeu Sciences Inc. (NASDAQ:CNXU) ("Conexeu" or the "Company"), a preclinical-stage medical device and regenerative medicine company advancing CXU™, an investigational tissue-restoration platform, today announced a human collagen program for regenerative aesthetics, starting with the production of its first pilot batch of human type I collagen.